Bioproximity
Precision in Protein Analysis for Biomarker Discovery and Clinical Guidance
Precision in Protein Analysis for Biomarker Discovery and Clinical Guidance
### Bioproximity: Precision in Protein Analysis for Biomarker Discovery and Clinical Guidance
Bioproximity was founded in 2008 and operates in the Biotechnology and Health Care industries. The company specializes in protein analysis and informatics for biomarker discovery, assay development, and clinical trial guidance. Their focus includes identifying and validating protein biomarkers, and they have a particular expertise in post-translational modifications such as glycosylations and phosphorylations.
Bioproximity provides a comprehensive range of shotgun proteomics services tailored for a diverse array of applications. Their slogan "Precision in Protein Analysis for Biomarker Discovery and Clinical Guidance" encapsulates the company's commitment to delivering high-quality, impactful solutions in the field of protein analysis.
As of now, there are no specific details available regarding the headquarters or the last investment, including the investors involved. However, given their niche expertise and the increasing importance of protein analysis in the biotech and healthcare sectors, Bioproximity presents an intriguing opportunity for investors seeking exposure to this specialized and evolving field.
There is no investment information
No recent news or press coverage available for Bioproximity.
We care about your data, and we'd love to use cookies make your experience better.